This federal contract award, valued at $43,012.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1041|SPE2DB25FTYY1) for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/28/25, 10:48 AM